Manchester Cancer Research Centre

Manchester Cancer Research Centre is an establishment dedicated to conducting cutting-edge research in the field of cancer. Located at the Oglesby Building on 555 Wilmslow Rd in Manchester, this institution serves as a hub of innovative research and development for cancer treatments and therapies. As a point of interest, the centre is open for public viewing and tours, allowing visitors to witness firsthand the remarkable advancements being made in the fight against cancer.

At Manchester Cancer Research Centre, world-class scientists, researchers, and doctors work in state-of-the-art facilities to develop new and effective cancer treatments. Founded through a pioneering partnership between the University of Manchester, the Cancer Research UK (CRUK) Manchester Institute, and The Christie NHS Foundation Trust, this institution symbolizes the collaborative effort to find new treatments and cures for cancer. Their groundbreaking work enables them to develop new insights into cancer biology, identify new drug targets, and design clinical trials to test promising therapies.

At the Oglesby Building, visitors can observe the researchers at work and learn about the latest discoveries in cancer research. The building features cutting-edge technology, including specialist labs and microscope facilities. Researchers study cancer samples from patients to understand the underlying mechanisms of the disease and test new therapies to treat different types of cancer. The centre operates on a translational model, which means research is conducted from bench to bedside, ensuring discoveries are brought to patients as soon as possible.

Manchester Cancer Research Centre is dedicated to making a difference for cancer patients. Through their revolutionary research and innovative treatments, they are committed to finding a cure for cancer. Their commitment to cancer research and treatment makes them one of the leading institutions in the UK and the world for cancer research. Together with their partners, they strive to eradicate the disease and improve the lives of cancer patients worldwide.